6. Institute Public Advisory Committees

• National Heart, Lung, and Blood Advisory Council
• National Heart, Lung, and Blood Advisory Council Membership
• Program Advisory and Review Committee
  • Sickle Cell Disease Advisory Committee
  • Sleep Disorders Research Advisory Board
  • Heart, Lung, and Blood Initial Review Group
  • Heart, Lung, and Blood Program Project Review Committee
  • Clinical Trials Review Committee
  • NHLBI Institutional Training Mechanism Review Committee
  • National Heart, Lung, and Blood Institute Special Emphasis Panel
  • Board of Scientific Counselors

National Heart, Lung, and Blood Advisory Council

Structure

Chair: Susan B. Shurin, M.D., Acting Director, NHLBI

Executive Secretary: Stephen C. Mockrin, Ph.D., Director, Division of Extramural Research Activities, NHLBI, National Institutes of Health, Bethesda, MD 20892; 301–435–0260

The Secretary of HHS appoints 18 members:  12 members are leading representatives of the health and scientific disciplines (including public health and behavioral or social sciences), and 6 are from the general public and are leaders in the fields of public policy, law, health policy, economics, and management.

Members are appointed for overlapping terms of 4 years.

The Council includes the following ex officio members:

• Secretary, HHS
• Director, NIH  
• Director, NHLBI  
• Chief Medical Director, Veterans Affairs, or Designee  
• Assistant Secretary of Defense for Health Affairs, or Designee
• Designee, Centers for Disease Control and Prevention

Functions

The NHLBAC reviews applications for research grants, cooperative agreements, and training grants in heart, blood vessel, lung, and blood diseases; sleep disorders; and blood resources, and recommends scientific projects that merit support to the Director, NHLBI.

The Council advises the Secretary, HHS; the Assistant Secretary for Health, HHS; and the Directors, NIH and NHLBI on matters relating to causes, prevention, diagnosis, and treatment of diseases and resources within the purview of the Institute. The Council also may review any grant, contract, or cooperative agreement proposed to be made or entered into by the Institute; may make recommendations to the Director of the Institute respecting research conducted at the Institute; may collect, by correspondence or by personal investigation, information as to studies that are being carried on in the United States or any other country with respect to the cause, prevention, diagnosis, and treatment of heart, blood vessel, lung, and blood diseases, and to the use of blood and blood products and the management of blood resources and, with the approval of the Director of the Institute, make available such information through appropriate publications for the benefit of public and private health entities and health professions personnel and scientists and for the information of the general public; and may assemble ad hoc working groups, appoint subcommittees, and convene workshops and conferences.

The Council may also make recommendations to the Director, NIH and other authorized officials regarding the acceptance of conditional gifts pursuant to section 231 of the Public Health Service Act, as amended.

Meetings

The Chair convenes meetings not fewer than four times a year and approves the agenda.

National Heart, Lung, and Blood Advisory Council Membership*

Susan B. Shurin, M.D.
Chair
National Heart, Lung, and Blood Institute

Jonathan R. Alger, J.D. (2014)
Rutgers, The State University of New Jersey

C. Noel Bairey Merz, M.D. (2011)
Cedars-Sinai Medical Center

Coletta C. Barrett, R.N. (2014)
Mission for Our Lady of the Lake Regional Medical Center

Ivor J. Benjamin, M.D. (2014)
University of Utah School of Medicine

Ingrid B. Borecki, Ph.D. (2012)
Washington University in St. Louis

Barry S. Coller, M.D. (2012)
The Rockefeller University

Jack A. Elias, M.D. (2012)
Yale University School of Medicine

Gary H. Gibbons, M.D. (2013)
Morehouse School of Medicine

Beverly W. Hogan (2012)
Tougaloo College

Lanetta B. Jordan, M.D. (2013)
Memorial Healthcare System

Talmadge E. King, M.D. (2013)
University of California, San Francisco

Naomi L.C. Luban, M.D. (2014)
The George Washington University School of Medicine

Andrew R. Marks, M.D. (2011)
Columbia University

Michael S. Parmacek, M.D. (2012)
University of Pennsylvania School of Medicine

Polly E. Parsons, M.D. (2014)
University of Vermont

Marlene Rabinovitch, M.D. (2011)
Stanford University

Leslee J. Shaw, Ph.D. (2013)
Emory University

Gilbert C. White II, M.D. (2014)
Blood Center of Wisconsin

Ex Officio Members

Francis S. Collins, M.D., Ph.D.
National Institutes of Health

Robert L. Jesse, M.D., Ph.D.
Veterans Health Administration

Kathleen Sebelius, M.P.A.
Department of Health and Human Services

Back to Top

Program Advisory and Review Committee

Sickle Cell Disease Advisory Committee

Chair:  Edward J. Benz, M.D., Dana-Farber Cancer Institute

Executive Secretary:  W. Keith Hoots, M.D., Director, Division of Blood Diseases and Resources, NHLBI, National Institutes of Health, Bethesda, MD 20892; 301–435–0080

The Sickle Cell Disease Advisory Committee advises the Directors of the NIH, the NHLBI, and the DBDR on matters related to planning, executing, conducting, supporting, and evaluating research in SCD.

Membership*

Thomas D. Coates, M.D. (2013)
University of Southern California

Elaine K. Gallin, Ph.D. (2012)
Doris Duke Charitable Foundation

Nigel S. Key, M.D. (2013)
University of North Carolina at Chapel Hill

Roberto F. Machado, M.D. (2012)
University of Illinois, Chicago

Punam Malik, M.D. (2012)
Cincinnati Children's Hospital Medical Center

Leslie V. Parise, Ph.D. (2012)
University of North Carolina

Ex Officio Members

Francis S. Collins, M.D., Ph.D.
National Institutes of Health

William Hannon, Ph.D.
Centers for Disease Control and Prevention

Marie Y. Mann, M.D.
Health Resources and Services Administration

David E. McCune, M.D.
Madigan Army Medical Center

Sleep Disorders Research Advisory Board

Chair:  Michael V. Vitiello, Ph.D., University of Washington

Executive Secretary:  Michael J. Twery, Ph.D., Director, National Center on Sleep Disorders Research, NHLBI, National Institutes of Health, Bethesda, MD 20892; 301–435–0202

The Sleep Disorders Research Advisory Board advises the Directors of the NIH, the NHLBI, and the NCSDR on matters related to planning, executing, conducting, supporting, and evaluating research in sleep disorders.

Membership*

Mercedes R. Carnethon, Ph.D., M.P.H. (2013)
Northwestern University

Ronald D. Chervin, M.D. (2012)
University of Michigan

Leszek K. Kubin, Ph.D. (2014)
University of Pennsylvania

Sairam Parthasarathy, M.D. (2014)
University of Arizona

R. Daniel Rudic, Ph.D. (2012)
Medical College of Georgia

Catherine Vena, Ph.D., R.N. (2013)
Emory University

Gagandeep Walia, M.B.A. (2013)
Visa, Inc.

Ex Officio Members

Thomas J. Balkin, Ph.D.
Walter Reed Army Institute of Research

Francis S. Collins, M.D., Ph.D.
National Institutes of Health

Robert W. Greene, M.D., Ph.D.
Veterans Administration, North Texas Medical Center

Rosalind King, Ph.D.
NICHD, National Institutes of Health

Miroslav Mackiewicz, Ph.D.
NIA, National Institutes of Health

Merrill M. Mitler, Ph.D.
NINDS, National Institutes of Health

Michael J. Twery, Ph.D.
NHLBI, National Institutes of Health

Aleksandra Vicentric, Ph.D.
NIMH, National Institutes of Health

Heart, Lung, and Blood Initial Review Group

Scientific Review Officer:  Jeffery H. Hurst, Ph.D., Scientific Review Officer, Division of Extramural Research Activities, NHLBI, National Institutes of Health, Bethesda, MD 20892; 301–435–0303

The Heart, Lung, and Blood Initial Review Group provides initial technical merit review for the NHLBAC and the Director, NHLBI.  This group consists of three subcommittees:  the Heart, Lung, and Blood Program Project Review Committee; the Clinical Trials Review Committee; and the NHLBI Institutional Training Mechanism Review Committee.

Heart, Lung, and Blood Program Project Review Committee

Chair:  David J. Pinsky, M.D., University of Michigan

Scientific Review Officer:  Jeffery H. Hurst, Ph.D., Scientific Review Officer, Division of Extramural Research Activities, NHLBI, National Institutes of Health, Bethesda, MD 20892; 301–435–0303

The Heart, Lung, and Blood Program Project Review Committee provides initial technical merit review for the NHLBAC and the Director, NHLBI on program project applications proposing research in the areas of heart, lung, and blood diseases and resources.

Membership*

David Atkinson, Ph.D. (2012)
Boston University School of Medicine

Peter M. Buttrick, M.D. (2014)
University of Colorado

Jennifer L. Hall, Ph.D. (2015)
University of Minnesota

Thomas H. Hintze, Ph.D. (2014)
New York Medical College

Pedro A. Jose, M.D., Ph.D. (2015)
Children's National Medical Center

Jay K. Kolls, M.D. (2014)
University of Pittsburgh School of Medicine

Monica Kraft, M.D. (2014)
Duke University Medical Center

Lucy Liaw, Ph.D. (2014)
Maine Medical Center Research Institute

Nigel Mackman, Ph.D. (2013)
University of North Carolina at Chapel Hill

Catherine S. Manno, M.D. (2013)
New York University School of Medicine

Fernando D. Martinez, M.D. (2013)
University of Arizona

Christine S. Moravec, Ph.D. (2012)
The Cleveland Clinic Foundation

Nanduri R. Prabhakar, Ph.D., D.Sc. (2012)
University of Chicago

Frank C. Sciurba, M.D. (2013)
University of Pittsburgh

Nancy S. Speck, Ph.D. (2013)
University of Pennsylvania School of Medicine

James C. Zimring, M.D., Ph.D. (2015)
Emory University School of Medicine

Clinical Trials Review Committee

Chair:  Julio A. Panza, M.D., Washington Hospital Center

Scientific Review Officer:  Keary A. Cope, Ph.D., Scientific Review Officer, Division of Extramural Research Activities, NHLBI, National Institutes of Health, Bethesda, MD 20892; 301–435–2222

The Clinical Trials Review Committee provides initial technical merit review for the NHLBAC and the Director of the NHLBI on clinical trial applications for the support of studies to evaluate preventive or therapeutic measures of blood, cardiovascular, and lung diseases.

Membership*

Roberta A. Ballard, M.D. (2014)
University of California, San Francisco

Bruce A. Barton, Ph.D. (2014)
University of Massachusetts Medical School

Jeffrey L. Carson, M.D. (2014)
University of Medicine and Dentistry of New Jersey

Mina K. Chung, M.D. (2014)
Case Western Reserve University

Gerard J. Criner, M.D. (2014)
Temple University School of Medicine

Karen L. Margolis, M.D. (2012)
Health Partners Research Foundation

Lori J. Mosca, M.D., Ph.D. (2013)
Columbia University Medical Center

Steven Piantadosi, M.D., Ph.D. (2013)
Cedars-Sinai Medical Center

Arshed A. Quyyumi, M.D. (2013)
Emory University School of Medicine

Gary E. Raskob, Ph.D. (2015)
University of Oklahoma Health Sciences Center

Margaret M. Redfield, M.D. (2013)
Mayo Clinic

Madeline M. Rice, Ph.D. (2013)
The George Washington University

Amy D. Shapiro, M.D. (2012)
Indiana Hemophilia and Thrombosis Center, Inc.

Stanley J. Szefler, M.D. (2012)
National Jewish Health

Barbara C. Tilley, Ph.D. (2015)
University of Texas

O. Dale Williams, Ph.D. (2015)
Florida International University

Back to Top

NHLBI Institutional Training Mechanism Review Committee

Chair:  William C. Balke, M.D., University of California, San Francisco

Scientific Review Officer:  Charles Joyce, Ph.D., Scientific Review Officer, Division of Extramural Research Activities, NHLBI, National Institutes of Health, Bethesda, MD 20892; 301–435–0291

The NHLBI Institutional Training Mechanism Review Committee provides initial technical merit review for the NHLBAC and the Director of the NHLBI on training applications that provide predoctoral, postdoctoral, and short-term research training at academic institutions.

Membership*

Ifeanyi J. Arinze, Ph.D. (2012)
Meharry Medical College

Jennifer K. Barton, Ph.D. (2015)
University of Arizona

Neil Blumberg, M.D. (2015)
University of Rochester

Meredith Bond, Ph.D. (2013)
University of Maryland School of Medicine

Kathleen B. Brosnihan, Ph.D. (2015)
Wake Forest University

Linda J. Burns, M.D. (2013)
University of Minnesota

David M. Center, M.D. (2013)
Boston University School of Medicine

Mark W. Geraci, M.D. (2015)
University of Colorado

David M. Guidot, M.D. (2015)
Emory University

Gerardo Heiss, M.D., Ph.D. (2014)
University of North Carolina at Chapel Hill

Kirk U. Knowlton, M.D. (2013)
University of California, San Diego

Robert J. Levy, M.D. (2014)
The Children's Hospital of Philadelphia

Alice H. Lichtenstein, D.Sc. (2013)
Tufts University

Russell V. Luepker, M.D. (2012)
University of Minnesota

Jonathan C. Makielski, M.D. (2012)
University of Wisconsin Hospitals and Clinics

William H. Pearce, M.D. (2014)
Northwestern University

Michael I. Phillips, Ph.D., D.Sc. (2014)
Keck Graduate Institute

Josef  T. Prchal, M.D. (2012)
University of Utah

Robin Shandas, Ph.D. (2012)
University of Colorado Health Sciences Center

Kingman P. Strohl, M.D. (2015)
University Hospitals of Cleveland

Mary I. Townsley, Ph.D. (2012)
University of South Alabama

Carolyn F. Whitsett, M.D. (2015)
Kings County Hospital

Jo Rae Wright, Ph.D. (2014)
Duke University

Back to Top

National Heart, Lung, and Blood Institute Special Emphasis Panel

The Institute established the NHLBI Special Emphasis Panel (SEP) to carry out the initial peer review of applications and proposals that were previously handled by ad hoc committees.  Concept review, previously handled by divisional program advisory committees, has also been incorporated into the SEP system.  The SEP, which has neither a fixed membership nor a set meeting schedule, is constituted to provide required peer review expertise at precisely the time that it is needed.

Board of Scientific Counselors

Chair: Michael I. Kotlikoff, V.M.D., Ph.D., Cornell University

Executive Secretary: Robert S. Balaban, Ph.D., Director, Division of Intramural Research, NHLBI, National Institutes of Health, Bethesda, MD 20892; 301–496–2116

The Board of Scientific Counselors advises the Director and the Deputy Director for Intramural Research, NIH, and the Directors of NHLBI and the Division of Intramural Research, NHLBI, on the intramural research programs of the NHLBI.

Membership*

Grover C. Bagby, M.D. (2015)
Oregon Health Sciences University

Kenneth R. Chien, M.D., Ph.D. (2012)
Massachusetts General Hospital

Serpil C. Erzurum, M.D. (2015)
The Cleveland Clinic Foundation

James F. Greenleaf, Ph.D. (2015)
Mayo Clinic College of Medicine

Aldons J. Lusis, Ph.D. (2013)
University of California, Los Angeles

David J. Sahn, M.D. (2014)
Oregon Health and Science University

Douglas C. Wallace, Ph.D. (2014)
University of California, Irvine

* Current as of October 2011. The current roster, containing full addresses for the NHLBI Advisory Council and Committees, can be obtained from the Internet at http://www.nhlbi.nih.gov/meetings/nhlbac/roster.htm.

Back to Top

« Fact Book Table of Contents